Georgios Ponirakis Selected Research

NAD (NADH)

10/2022	Progressive loss of corneal nerve fibers is associated with physical inactivity and glucose lowering medication associated with weight gain in type 2 diabetes.
9/2022	Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region.
4/2022	Corneal Confocal Microscopy Identifies People with Type 1 Diabetes with More Rapid Corneal Nerve Fibre Loss and Progression of Neuropathy.
1/2022	Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta-analysis.
9/2021	Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
4/2021	Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar.
1/2021	Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres.
1/2021	Vitamin D deficiency is associated with painful diabetic neuropathy.
1/2021	Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study.
1/2020	Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Georgios Ponirakis Research Topics

Disease

21	Peripheral Nervous System Diseases (PNS Diseases) 10/2022 - 01/2015
14	Diabetic Neuropathies (Diabetic Neuropathy) 03/2022 - 01/2013
10	Type 2 Diabetes Mellitus (MODY) 10/2022 - 04/2015
7	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2022 - 01/2015
5	Ischemic Stroke 10/2021 - 11/2017
4	Obesity 09/2022 - 01/2021
4	Hypertension (High Blood Pressure) 09/2022 - 01/2019
4	Stroke (Strokes) 01/2022 - 11/2017
4	Pain (Aches) 09/2021 - 04/2015
3	Diabetic Foot 09/2022 - 01/2021
3	Small Fiber Neuropathy 08/2015 - 01/2015
2	Body Weight (Weight, Body) 10/2022 - 01/2020
2	Weight Gain 10/2022 - 09/2021
2	Hyperlipidemias (Hyperlipidemia) 09/2022 - 04/2021
2	Neuralgia (Stump Neuralgia) 01/2021 - 12/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2021 - 01/2013
2	Hyperalgesia 01/2021 - 01/2017
2	Diabetes Mellitus 11/2020 - 11/2017
2	Glucose Intolerance 11/2017 - 09/2014
1	Weight Loss (Weight Reduction) 10/2022
1	Hypertriglyceridemia 07/2022
1	Neuroinflammatory Diseases 03/2022
1	Inflammation (Inflammations) 01/2022
1	Schizophrenia (Dementia Praecox) 01/2022
1	Insulin Resistance 11/2021
1	Ulcer 01/2021
1	Painful Neuropathy 01/2021
1	Hypesthesia (Numbness) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Morbid Obesity 01/2021
1	Vitamin D Deficiency 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Cognitive Dysfunction 01/2020
1	Dementia (Dementias) 01/2020
1	Atrophy 01/2020
1	Proteinuria 11/2019
1	Nerve Degeneration 01/2017
1	Multiple Sclerosis 01/2017
1	Parkinson Disease (Parkinson's Disease) 12/2015
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

20	NAD (NADH)IBA 10/2022 - 01/2015
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2014
5	Triglycerides (Triacylglycerol)IBA 07/2022 - 11/2018
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 09/2014
4	diazonaphthalenedisulfonic acid (NDS)IBA 07/2022 - 04/2015
4	LipidsIBA 07/2022 - 03/2021
3	oxidized low density lipoproteinIBA 10/2022 - 01/2020
3	Insulin (Novolin)FDA Link 01/2020 - 01/2015
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021 - 11/2020
2	CholesterolIBA 01/2021 - 01/2020
1	MicroRNAs (MicroRNA)IBA 03/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	hydroxide ionIBA 01/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2021
1	Lipoproteins (Lipoprotein)IBA 01/2021
1	HDL CholesterolIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	N 30IBA 12/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2017
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2017
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2016
1	Levodopa (L Dopa)FDA LinkGeneric 12/2015
1	PlatinumIBA 01/2015

Therapy/Procedure

5	Glycemic Control 09/2022 - 11/2019
3	Therapeutics 09/2021 - 01/2017
3	Surgical Amputation (Amputations) 01/2021 - 01/2019
3	Kidney Transplantation 01/2021 - 01/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2015
1	Bariatric Surgery 01/2021
1	Denervation 12/2015